<DOC>
	<DOCNO>NCT00065312</DOCNO>
	<brief_summary>The purpose study determine investigational drug safe efficacious poorly control type 2 diabetes mellitus .</brief_summary>
	<brief_title>An Evaluation Oral Antidiabetic Agent Treatment Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diagnosis Type 2 Diabetes least 3 month . Diabetes manage diet exercise alone either metformin sulfonylurea alone adjunct diet exercise . Diabetes therapy must unchanged least 3 month prior screen . Females must nonchildbearing potential ( surgically sterilize least 1 year postmenopausal , define cessation menses ) . Female patient surgically sterilize less equal 45 year postmenopausal status confirm FSH great 30ng/mL screening . Current use insulin antidiabetic agent sulfonylurea agent metformin . Current use metformin sulfonylurea agent combination . History liver disease . History unstable angina ( define Braunwald system ) , myocardial infarction , coronary revascularization procedure within past 6 month . Currently suspect carcinoma history carcinoma last 5 year , exception excise superficial lesion basal cell carcinoma squamous cell carcinoma skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Type 2 diabetes</keyword>
</DOC>